tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Gilead price target raised to $135 from $125 at Citi

Citi analyst Geoff Meacham raised the firm’s price target on Gilead (GILD) to $135 from $125 and keeps a Buy rating on the shares. Citi’s survey of 100 physicians indicates strong initial trends for the Yeztugo launch in HIV, the analyst tells investors in a research note. The firm upped sales forecasts and the price target as a result.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1